GLYNN WILSON
CIK 1405625 · Chief Executive Officer · last filed 2026-03-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$945.0K
Companies
5
Total Filings
24
Lifetime Open-Market Net
-$139.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CABR | Chief Executive Officer | 672,592 | $1.13 | $760.0K | $0 | 2 | 2026-03-27 |
| CVKD | Director | 50,000 | $3.70 | $185.0K | $0 | 3 | 2025-01-24 |
| BONK, INC. (SHOTW) Delisted | Former CSO, Chairman | — | $0.04 | — | $0 | 1 | 2024-03-06 |
| BONK, INC. (JUPWW) Delisted | CSO, Chairman | 950,000 | $0.32 | $304.0K | -$139.5K | 9 | 2022-12-30 |
| Marker Therapeutics, Inc. (TPIV) Delisted | Chief Executive Officer | 181,776 | — | — | $0 | 4 | 2018-10-10 |
Recent Filings · Page 3 of 3
24 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-11-13 | — | Mixed | +633,319 | $530.7K | |
| 2012-04-24 | — | Other (J) | +166,667 | $25.0K | |
| 2011-04-05 | — | Other (J) | +147,059 | $25.0K | |
| 2009-10-26 | — | Mixed | +900,000 | $90.0K |
Showing 21–24 of 24
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.